Roberto Ortiz

Summary

Publications

  1. ncbi Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
    Roberto Ortiz
    Orlando Immunology Center, Orlando, Florida, USA
    AIDS 22:1389-97. 2008
  2. ncbi Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily
    Richard Elion
    Whitman Walker Clinic, Washington, DC 20009, USA
    HIV Clin Trials 9:213-24. 2008

Detail Information

Publications2

  1. ncbi Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
    Roberto Ortiz
    Orlando Immunology Center, Orlando, Florida, USA
    AIDS 22:1389-97. 2008
    ....
  2. ncbi Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily
    Richard Elion
    Whitman Walker Clinic, Washington, DC 20009, USA
    HIV Clin Trials 9:213-24. 2008
    ....